NST:ASXNorthern Star Resources Ltd Analysis
Data as of 2026-06-18 - not real-time
A$21.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Northern Star Resources trades around AUD 21.5, sitting just above its 20‑day SMA (19.8) and 50‑day SMA (21.2) but well below the 200‑day SMA (24.1), indicating a medium‑term bearish bias. The MACD is bullish with a positive histogram, while the RSI at 56 suggests neutral momentum. Support sits near AUD 17.55 and resistance near AUD 22.79, with decreasing volume and a 30‑day volatility of over 67%, pointing to heightened short‑term risk. Fundamentally, the company posted 19% revenue growth, solid gross (38%) and operating (30%) margins, and a dividend yield of 2.29% backed by a payout ratio under 50%.
Recent material news includes a $1 billion stake taken by Elliott Management and a forthcoming CEO transition, both of which could catalyze strategic shifts. Despite these positives, the DCF‑derived fair value of roughly AUD 5.2 is far below the current price, suggesting the stock is priced for optimism and may be overvalued in the near term.
Recent material news includes a $1 billion stake taken by Elliott Management and a forthcoming CEO transition, both of which could catalyze strategic shifts. Despite these positives, the DCF‑derived fair value of roughly AUD 5.2 is far below the current price, suggesting the stock is priced for optimism and may be overvalued in the near term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near resistance with decreasing volume
- Technical bearish trend despite bullish MACD
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Activist stake and potential strategic overhaul
- Strong revenue growth and margin profile
- Sustainable dividend with comfortable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Exposure to gold as a long‑term inflation hedge
- Consistent cash flow generation and low leverage relative to cash
- Management succession plan aimed at sustaining expansion
Key Metrics & Analysis
Financial Health
Revenue Growth19.00%
Profit Margin22.24%
P/E Ratio18.2
ROE12.80%
ROA8.15%
Debt/Equity11.77
P/B Ratio2.0
Op. Cash FlowA$2.7B
Free Cash FlowA$287.8M
Technical Analysis
TrendBearish
RSI56.4
SupportA$17.55
ResistanceA$22.79
MA 20A$19.82
MA 50A$21.17
MA 200A$24.11
MACDBullish
VolumeDecreasing
Fear & Greed Index91.48
Valuation
Fair ValueA$5.19
Target PriceA$25.99
Upside/Downside20.87%
GradeOvervalued
TypeBlend
Dividend Yield2.29%
Risk Assessment
Beta1.24
Volatility67.33%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.